Literature DB >> 3554494

Immunological involvement in the pathogenesis of pristane-induced arthritis.

A E Bedwell, C J Elson, C E Hinton.   

Abstract

Evidence is presented that the development of arthritis induced in mice by 2,6,10,14-tetramethylpentadecane (pristane) involves the immune response. Mice irradiated (500 rad) before injection of pristane failed to develop arthritis. By contrast, irradiated mice given lymphoid cells from normal donors and challenged with pristane developed arthritis. Other experiments showed that lymphoid cells from irradiated mice given pristane suppressed the development of arthritis in recipients challenged with pristane. Finally, the incidence of arthritis was significantly higher in CBA/Igb mice given pristane than in the allotypic congenic strain CBA/H, suggesting that a gene linked to the heavy chain immunoglobulin locus controls the development of arthritis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3554494     DOI: 10.1111/j.1365-3083.1987.tb02205.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  11 in total

1.  Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG.

Authors:  S J Thompson; Y Hitsumoto; Y W Zhang; G A Rook; C J Elson
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes.

Authors:  C Vingsbo; P Sahlstrand; J G Brun; R Jonsson; T Saxne; R Holmdahl
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 3.  Rodent models of arthritis: relevance for human disease.

Authors:  R O Williams
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

4.  Pristane-induced arthritis is CD4+ T-cell dependent.

Authors:  L M Stasiuk; M Ghoraishian; C J Elson; S J Thompson
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

5.  Prevention of pristane-induced arthritis by the oral administration of type II collagen.

Authors:  S J Thompson; H S Thompson; N Harper; M J Day; A J Coad; C J Elson; N A Staines
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

6.  The route of administration of an immunodominant peptide derived from heat-shock protein 65 dramatically affects disease outcome in pristane-induced arthritis.

Authors:  J N Francis; A G Lamont; S J Thompson
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

Review 7.  Role of immunity to mycobacterial stress proteins in rheumatoid arthritis.

Authors:  L McLean; V Winrow; D Blake
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

8.  B- and T-cell autoantigens in pristane-induced arthritis.

Authors:  R N Barker; A J Easterfield; R F Allen; A D Wells; C J Elson; S J Thompson
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

9.  Comparison between the protective effects of mycobacterial 65-kD heat shock protein and ovomucoid in pristane-induced arthritis: relationship with agalactosyl IgG.

Authors:  M Ghoraishian; C J Elson; S J Thompson
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

Review 10.  Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies.

Authors:  Katina Schinnerling; Carlos Rosas; Lilian Soto; Ranjeny Thomas; Juan Carlos Aguillón
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.